2016 American Transplant Congress

June 11-15, 2016 in Boston, MA

View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

CMV Immune Monitoring with a CMV ELISPOT Test in Kidney Transplant Patients.

S. Ball, A. Small, C. Waite.
CMV Monitoring Reduces Risk of Clinical Complications in Kidney Transplant Recipients.

A. Gilbert, M. Cooper, J. Verbesey, R. Ghasemian, P. Abrams, J. Moore, M. Grafals, J. Chahine, S. Punnett, E. Hall, I. Anzak, B. Javaid.
CMV-Accelerated Cardiac Allograft Rejection Is Associated with Dysregulation of Sphingolipid Metabolomics.

J. Burg,¹ T. Andoh,² N. Haese,² C. Kreklywich,² K. Watters,³ T. Metz,³ S. Orloff,¹ D. Streblow.²
CoCl2 Induced ER Stress Protein Mediated Cytotoxicity in FK506 Treated Hepatoma HepG2 Cells.

S. Choi, S. Chung.
Cognitive Impairment in Kidney Transplant Recipients.

A. Gupta,¹ D. Johnson,¹ G. Chen,¹ D. Subramaniam,¹ T. Polshak,¹ T. Thomas,¹ T. Schmitt,¹ D. Ladner,² A. Yu,¹ J. Burns.¹
Cold Ischemia Induced Outcomes in Kidney Transplantation: A Meta-Analysis.

D. Bennett, M. Mustafa, M. Chiles, W. Skillen, S. Mohan.
Cold Storage Stabilization of Gap Junctions Reduces Post Transplant Ischemia Reperfusion Injury.

R. Finnegan,¹ P. Zhu,¹ S. Stephenson,¹ K. Patel,² S. Nadig,^1,2,3 C. Atkinson.^1,2,3
Colonization and Risk of Bacteremia by Multi-Drug Resistant Organisms in Intestinal Transplant Recipients.

J. Simkins,¹ J. Camargo,¹ M. Morris,¹ R. Vianna,² T. Beduschi,² L. Abbo.¹
Combination of Delayed Kidney Transplant (KT) and Better Quality Kidneys Offers Excellent Patient Survival in Combined Liver-Kidney Transplantation (CLKT).

B. Ekser, R. Mangus, J. Fridell, C. Kubal, D. Bayt, S. Nagaraju, P. Mihaylov, J. Powelson, W. Goggins, A. Tector.
Combination of Veto Cell Transfer and iNKT Cell Therapy Establishes Complete Hematopoietic Chimerism in Non-Myeloablative BMT Recipients.

R. Ishii,¹ T. Hirai,¹ Y. Ishii,² K. Tanabe.¹

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z